Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

Expert Rev Anticancer Ther. 2012;12(1):41-49. Uterine serous cancer (USC) is a highly aggressive variant of endometrial cancer. USC is resistant to cytotoxic chemotherapy and is responsible for ...

Most uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

Inquirer reporter Julie Alipala, who spent decades covering conflicts and peace-building efforts in Mindanao, died early ...

The safety and efficacy of dostarlimab plus chemotherapy in patients with advanced endometrial cancer were confirmed by ...

Julie Alipala, a longtime Zamboanga-based reporter for the Philippine Daily Inquirer who covered wars, conflicts, and peace ...